Company Profile

AstraZeneca plc (NYSE: AZN)
Pricing data not available
Detailed Quote
Open: $ n/a   Volume: n/a
High: $ n/a   Yield(%) n/a
Low: $ n/a   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): n/a
EPS ($) n/a   Shares Out: n/a
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -3.74
% Price Change (last 13 weeks): 8.94
% Price Change (last 26 weeks): 15.18
% Price Change (last 52 weeks): 2.82
% Price Change (year to date): 15.34
Management Effectiveness
Return on Equity (%): 22.41
Return on Assets (%): 5.03
Return on Invested Capital (%): 8.66
Gross Profit Margin (%): 74.01
Net Profit Margin (%): 11.58
Operating Profit Margin (%): 16.98
Price & Volume
50-day Moving Average: $58.12
200-day Moving Average: $53.32
Avg. Daily Vol. (last 50 days): 11,559,082
Avg. Daily Vol. (last 200 days): 10,414,410
52-wk high: $n/a
52-wk low: $n/a
Bid: $n/a
Ask: $n/a
Company Information
AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
AstraZeneca plc
Cambridge Biomedical Campus 1 Francis Crick Avenue
Cambridge CA CB2 0AA

Phone: 44.20.3749.5000
Fax: 44.12.2335.2858
Per Share Data
Earnings (1year) ($): 1.45
Annual Dividend ($): 1.37
Current P/E Ratio (ttm): n/a
Book Value ($): 5.95
Cash Flow ($): 2.34
Valuation Ratios
Price/Earnings (x): 39.86
Price/Sales (x): 4.72
Price/Book (x): 8.40
Price/Cash Flow (x): 26.88
Financial Strength
Quick Ratio (x): 0.76
Current Ratio (x): 0.96
LT Debt/Equity (x): 115.18
Total Debt/Equity (x): 130.46

Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.